AU2001276026A1 - B7-h2 molecules, novel members of the b7 family and uses thereof - Google Patents

B7-h2 molecules, novel members of the b7 family and uses thereof

Info

Publication number
AU2001276026A1
AU2001276026A1 AU2001276026A AU7602601A AU2001276026A1 AU 2001276026 A1 AU2001276026 A1 AU 2001276026A1 AU 2001276026 A AU2001276026 A AU 2001276026A AU 7602601 A AU7602601 A AU 7602601A AU 2001276026 A1 AU2001276026 A1 AU 2001276026A1
Authority
AU
Australia
Prior art keywords
family
molecules
novel members
novel
members
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276026A
Inventor
Anthony J. Coyle
Christopher C Fraser
Stephen Manning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Millennium Pharmaceuticals Inc
Original Assignee
Millennium Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharmaceuticals Inc filed Critical Millennium Pharmaceuticals Inc
Publication of AU2001276026A1 publication Critical patent/AU2001276026A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70532—B7 molecules, e.g. CD80, CD86
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001276026A 2000-07-20 2001-07-20 B7-h2 molecules, novel members of the b7 family and uses thereof Abandoned AU2001276026A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/620,461 US6635750B1 (en) 2000-07-20 2000-07-20 B7-H2 nucleic acids, members of the B7 family
US09620461 2000-07-20
PCT/US2001/023094 WO2002008279A2 (en) 2000-07-20 2001-07-20 B7-h2 molecules, novel members of the b7 family and uses thereof

Publications (1)

Publication Number Publication Date
AU2001276026A1 true AU2001276026A1 (en) 2002-02-05

Family

ID=24486045

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276026A Abandoned AU2001276026A1 (en) 2000-07-20 2001-07-20 B7-h2 molecules, novel members of the b7 family and uses thereof

Country Status (3)

Country Link
US (4) US6635750B1 (en)
AU (1) AU2001276026A1 (en)
WO (1) WO2002008279A2 (en)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041474B2 (en) * 1998-12-30 2006-05-09 Millennium Pharmaceuticals, Inc. Nucleic acid encoding human tango 509
US20080213778A1 (en) * 1998-12-30 2008-09-04 Millennium Pharmaceuticals, Inc. Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
US7708993B2 (en) 1999-02-03 2010-05-04 Amgen Inc. Polypeptides involved in immune response
US8624010B1 (en) 1999-02-03 2014-01-07 Steven K. Yoshinaga Nucleic acids encoding B7RP1
PT2332978E (en) 1999-02-03 2014-05-23 Amgen Inc Novel polypeptides involved in immune response
WO2001039722A2 (en) * 1999-11-30 2001-06-07 Mayo Foundation For Medical Education And Research B7-h1, a novel immunoregulatory molecule
US7030219B2 (en) * 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
US20030031675A1 (en) 2000-06-06 2003-02-13 Mikesell Glen E. B7-related nucleic acids and polypeptides useful for immunomodulation
EP1892251A3 (en) * 2000-06-06 2008-12-31 Brystol-Myers Squibb Company B7-related nucleic acids and polypeptides and their uses for immunomodulation
US6965018B2 (en) * 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
EP1320599A2 (en) * 2000-06-28 2003-06-25 Genetics Institute, LLC Pd-l2 molecules: pd-1 ligands and uses therefor
US6635750B1 (en) * 2000-07-20 2003-10-21 Millennium Pharmaceuticals, Inc. B7-H2 nucleic acids, members of the B7 family
US20040077043A1 (en) * 2000-09-12 2004-04-22 Hiroshi Watarai Novel dendritic cell wall membrane and use thereof
MXPA03002413A (en) * 2000-09-20 2003-06-19 Amgen Inc B7-like molecules and uses thereof.
AU2002258941A1 (en) * 2001-04-20 2002-11-05 Mayo Foundation For Medical Education And Research Methods of enhancing cell responsiveness
JP4181032B2 (en) * 2001-05-25 2008-11-12 アムジェン インコーポレーテッド B7-related protein-2 molecule and use thereof
EP1578385A4 (en) * 2001-10-19 2011-11-09 Genentech Inc Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
US7235631B2 (en) * 2002-02-07 2007-06-26 Mayo Foundation For Medical Education And Research ICOS mutants
US20040102398A1 (en) * 2002-11-23 2004-05-27 Isis Pharmaceuticals Inc. Modulation of B7H expression
EP1536821A4 (en) * 2002-06-17 2009-09-09 Wyeth Corp Inhibition of t cell activation by butyrophilin 4 or b7-l1
MXPA04012664A (en) 2002-06-19 2005-08-15 Raven Biotechnologies Inc Novel raag10 cell surface target and a family of antibodies recognizing that target.
US7432351B1 (en) 2002-10-04 2008-10-07 Mayo Foundation For Medical Education And Research B7-H1 variants
WO2005044999A2 (en) * 2003-11-05 2005-05-19 New England Medical Center Hospitals, Inc. Treatment with immunoregulatory t cells
US7732131B2 (en) 2004-08-03 2010-06-08 Innate Pharma S.A. Therapeutic and diagnostic methods and compositions targeting 4Ig-B7-H3 and its counterpart NK cell receptor
AU2005295038B2 (en) 2004-10-06 2012-05-17 Mayo Foundation For Medical Education And Research B7-H1 and methods of diagnosis, prognosis, and treatment of cancer
RU2596491C2 (en) 2005-06-08 2016-09-10 Дана-Фарбер Кэнсер Инститьют Methods and compositions for treating persistent infections
US20100015642A1 (en) * 2006-01-05 2010-01-21 Kwon Eugene D B7-h1 and survivin in cancer
WO2007082154A2 (en) * 2006-01-05 2007-07-19 Mayo Foundation For Medical Education And Research B7-h1 and b7-h4 in cancer
WO2007124361A2 (en) * 2006-04-20 2007-11-01 Mayo Foundation For Medical Education And Research Soluble b7-h1
KR101523391B1 (en) 2006-12-27 2015-05-27 에모리 유니버시티 Compositions and methods for the treatment of infections and tumors
WO2009029342A2 (en) 2007-07-13 2009-03-05 The Johns Hopkins University B7-dc variants
US20110020325A1 (en) * 2008-02-29 2011-01-27 Kwon Eugene D Methods for reducing granulomatous inflammation
EA201170375A1 (en) * 2008-08-25 2012-03-30 Эмплиммьюн, Инк. PD-1 ANTAGONISTS AND METHODS OF THEIR APPLICATION
KR20110050529A (en) 2008-08-25 2011-05-13 앰플리뮨, 인크. Compositions of pd-1 antagonists and methods of use
JP5686600B2 (en) * 2008-10-22 2015-03-18 株式会社メディネット New monoclonal antibodies and their uses
CN102282265B (en) 2008-11-28 2020-07-24 埃默里大学 Methods for treating infectious diseases and tumors
EP2376535B9 (en) 2008-12-09 2017-09-13 F. Hoffmann-La Roche AG Anti-pd-l1 antibodies and their use to enhance t-cell function
AU2010282340B2 (en) 2009-08-13 2016-12-22 The Johns Hopkins University Methods of modulating immune function
JP2013528360A (en) 2010-04-09 2013-07-11 アムジェン インコーポレイテッド BTNL9 proteins, nucleic acids and antibodies and uses thereof
JOP20140087B1 (en) 2013-03-13 2021-08-17 Amgen Inc Proteins specific for baff and b7rp1 and uses thereof
US9458246B2 (en) 2013-03-13 2016-10-04 Amgen Inc. Proteins specific for BAFF and B7RP1
US9302005B2 (en) 2013-03-14 2016-04-05 Mayo Foundation For Medical Education And Research Methods and materials for treating cancer
US10259875B2 (en) 2013-10-01 2019-04-16 Mayo Foundation For Medical Education And Research Methods for treating cancer in patients with elevated levels of BIM
US10302653B2 (en) 2014-05-22 2019-05-28 Mayo Foundation For Medical Education And Research Distinguishing antagonistic and agonistic anti B7-H1 antibodies
US10517875B2 (en) 2014-07-23 2019-12-31 Mayo Foundation for Medical Engineering and Research Targeting DNA-PKcs and B7-H1 to treat cancer
DK3283508T3 (en) 2015-04-17 2021-05-31 Alpine Immune Sciences Inc Immunomodulatory Proteins with Tunable Affinities
WO2017009843A2 (en) 2015-07-16 2017-01-19 Biokine Therapeutics Ltd. Compositions, articles of manufacture and methods for treating cancer
US10875923B2 (en) 2015-10-30 2020-12-29 Mayo Foundation For Medical Education And Research Antibodies to B7-H1
CN110753755B (en) 2016-03-21 2023-12-29 丹娜法伯癌症研究院 T cell depletion state specific gene expression regulator and application thereof
KR20230051601A (en) 2016-04-15 2023-04-18 알파인 이뮨 사이언시즈, 인코포레이티드 Icos ligand variant immunomodulatory proteins and uses thereof
IL262366B1 (en) 2016-04-15 2024-03-01 Alpine Immune Sciences Inc Cd80 variant immunomodulatory proteins and uses thereof
US20200270702A1 (en) * 2016-12-23 2020-08-27 Trustees Of Boston University Classification of diffuse large b-cell lymphoma
WO2018170023A1 (en) 2017-03-16 2018-09-20 Alpine Immune Sciences, Inc. Pd-l2 variant immunomodulatory proteins and uses thereof
EP3634584A4 (en) 2017-06-09 2021-04-07 Providence Health & Services - Oregon Utilization of cd39 and cd103 for identification of human tumor reactive cells for treatment of cancer
EA202090974A1 (en) 2017-10-18 2020-08-05 Элпайн Иммьюн Сайенсиз, Инк. VARIANT IMMUNOMODULATING PROTEINS OF ICOS LIGAND AND ACCOMPANYING COMPOSITIONS AND METHODS
EP4351595A1 (en) 2021-06-07 2024-04-17 Providence Health & Services - Oregon Cxcr5, pd-1, and icos expressing tumor reactive cd4 t cells and their use

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580756A (en) 1990-03-26 1996-12-03 Bristol-Myers Squibb Co. B7Ig fusion protein
US5851795A (en) 1991-06-27 1998-12-22 Bristol-Myers Squibb Company Soluble CTLA4 molecules and uses thereof
US6084067A (en) 1993-07-26 2000-07-04 Dana-Farber Cancer Institute CTLA4/CD28 ligands and uses therefor
US5861310A (en) 1993-11-03 1999-01-19 Dana-Farber Cancer Institute Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
US5942607A (en) 1993-07-26 1999-08-24 Dana-Farber Cancer Institute B7-2: a CTLA4/CD28 ligand
CA2167091A1 (en) 1993-07-26 1995-02-02 Gordon J. Freeman B7-2: ctl a4/cd 28 counter receptor
AU7526894A (en) 1993-08-16 1995-03-14 Arch Development Corporation B7-2: ctla4/cd28 counter receptor
JP2002515734A (en) 1996-01-02 2002-05-28 カイロン コーポレイション Immunostimulation mediated by genetically modified dendritic cells
WO2001034629A1 (en) 1999-11-12 2001-05-17 Human Genome Sciences, Inc. 21 human secreted proteins
WO2000037643A2 (en) 1998-12-23 2000-06-29 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU3899700A (en) 1999-03-17 2000-10-04 Alphagene, Inc. Secreted proteins and polynucleotides encoding them
PL354348A1 (en) 1999-04-02 2004-01-12 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
EP1074617A3 (en) 1999-07-29 2004-04-21 Research Association for Biotechnology Primers for synthesising full-length cDNA and their use
CA2396036A1 (en) 1999-12-30 2001-07-12 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
US7030219B2 (en) 2000-04-28 2006-04-18 Johns Hopkins University B7-DC, Dendritic cell co-stimulatory molecules
US6965018B2 (en) 2000-06-06 2005-11-15 Bristol-Myers Squibb Company Antibodies directed to B7-related polypeptide, BSL-2
EP1320599A2 (en) * 2000-06-28 2003-06-25 Genetics Institute, LLC Pd-l2 molecules: pd-1 ligands and uses therefor
US6635750B1 (en) * 2000-07-20 2003-10-21 Millennium Pharmaceuticals, Inc. B7-H2 nucleic acids, members of the B7 family
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof

Also Published As

Publication number Publication date
US20040137577A1 (en) 2004-07-15
WO2002008279A3 (en) 2002-06-27
US6630575B2 (en) 2003-10-07
US20020106730A1 (en) 2002-08-08
US20090269783A1 (en) 2009-10-29
WO2002008279A2 (en) 2002-01-31
US6635750B1 (en) 2003-10-21
US7432062B2 (en) 2008-10-07

Similar Documents

Publication Publication Date Title
AU2001276026A1 (en) B7-h2 molecules, novel members of the b7 family and uses thereof
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2001263466A1 (en) Soluble CTLA4 mutant molecules and uses thereof
AU2001283507A1 (en) B7-h3 and b7-h4, novel immunoregulatory molecules
AU2001249423A1 (en) 38692 and 21117, novel dual specificity phosphatase molecules and uses therefor
AUPQ339899A0 (en) Novel molecules
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2002245332A1 (en) Anergy-regulated molecules
AU2002368044A1 (en) Co-stimulatory molecules
AU2002330074A1 (en) Tall-1 receptor molecules and uses thereof
AU2002337312A1 (en) Molecules
AU2001275990A1 (en) 16816 and 16839, novel human phospholipase c molecules and uses therefor
AU2002362414A1 (en) Novel molecules of the hkid-1-related protein family and uses thereof
AU3512900A (en) Novel thioredoxin family active site molecules and uses therefor
AU2002257430A1 (en) Androgen-mediated neuroprotection and uses thereof
AU2001291235A1 (en) 22108 and 47916, novel human thioredoxin family members and uses thereof
AU2002363761A1 (en) Porus materials based on template-forming microorganisms
AUPQ884500A0 (en) Novel therapeutic molecules and uses therefor - III
AU2001253386A1 (en) Haplotypes of the impdh2 gene
AU2001288423A1 (en) Haplotypes of the bmpr2 gene
AU2001253101A1 (en) Haplotypes of the scn2b gene
AUPR849001A0 (en) Immunointeractive molecules and uses thereof
AU2002246541A1 (en) Rna polymers and uses thereof
AUPS161602A0 (en) Novel molecules and uses therefor
AU2001295337A1 (en) E. histolytica-specific antibodies and clinical uses thereof